The designation C14orf72 Inhibitors denotes a class of chemical entities designed to selectively hinder the activity of the C14orf72 protein. C14orf72, standing for Chromosome 14 Open Reading Frame 72, represents a gene that encodes a protein whose precise biological functions are yet to be fully elucidated. Scientific investigations into C14orf72 have intensified due to its suspected involvement in various cellular processes, and the development of inhibitors targeting this protein has emerged as a pivotal avenue for unraveling its molecular roles. As researchers delve into the complexities of C14orf72, inhibitory compounds are designed with meticulous precision, aiming to interfere with the protein's activity and thereby providing insights into its functional significance within cellular pathways.
The synthesis and optimization of C14orf72 inhibitors involve a thorough exploration of the protein's structure and biochemical properties. These inhibitors are crafted to interact selectively with specific regions of C14orf72, such as its active site, hindering its normal functions and allowing researchers to discern the consequences of such interference on cellular processes. By employing C14orf72 inhibitors as experimental tools, scientists can delve deeper into the underlying mechanisms governed by this protein, contributing to a broader understanding of its cellular functions. The development of this class of inhibitors marks a crucial step in the ongoing efforts to decipher the intricacies of cellular biology and unlock the mysteries surrounding the roles played by C14orf72 in normal physiological conditions and potential implications in pathological states.
| Product Name | CAS # | Catalog # | QUANTITY | Price | Citations | RATING |
|---|---|---|---|---|---|---|
Actinomycin D | 50-76-0 | sc-200906 sc-200906A sc-200906B sc-200906C sc-200906D | 5 mg 25 mg 100 mg 1 g 10 g | $74.00 $243.00 $731.00 $2572.00 $21848.00 | 53 | |
Actinomycin D inhibits transcription by intercalating into DNA, preventing RNA synthesis and indirectly reducing LINC00239 expression. | ||||||
Fluorouracil | 51-21-8 | sc-29060 sc-29060A | 1 g 5 g | $37.00 $152.00 | 11 | |
5-Fluorouracil interferes with nucleotide metabolism, leading to misincorporation into RNA and inhibiting LINC00239 expression. | ||||||
Rifampicin | 13292-46-1 | sc-200910 sc-200910A sc-200910B sc-200910C | 1 g 5 g 100 g 250 g | $97.00 $328.00 $676.00 $1467.00 | 6 | |
Rifampicin inhibits RNA synthesis by binding to bacterial RNA polymerase. While mainly used against bacteria, it may impact LINC00239 indirectly in certain cellular contexts. | ||||||
6-Mercaptopurine | 50-44-2 | sc-361087 sc-361087A | 50 mg 100 mg | $72.00 $104.00 | ||
6-Mercaptopurine, a purine analog, disrupts nucleotide metabolism, potentially inhibiting LINC00239 expression by interfering with RNA synthesis. | ||||||
α-Amanitin | 23109-05-9 | sc-202440 sc-202440A | 1 mg 5 mg | $269.00 $1050.00 | 26 | |
Alpha-Amanitin is a potent inhibitor of RNA polymerase II, the enzyme responsible for transcribing most protein-coding genes, and could indirectly reduce LINC00239 expression. | ||||||
6-Thioguanine | 154-42-7 | sc-205587 sc-205587A | 250 mg 500 mg | $42.00 $54.00 | 3 | |
6-Thioguanine, a guanine analog, interferes with nucleotide metabolism and may inhibit LINC00239 expression by disrupting RNA synthesis. | ||||||
Camptothecin | 7689-03-4 | sc-200871 sc-200871A sc-200871B | 50 mg 250 mg 100 mg | $58.00 $186.00 $94.00 | 21 | |
Camptothecin inhibits DNA topoisomerase I, impacting DNA replication and indirectly influencing LINC00239 expression by disrupting processes linked to its regulation. | ||||||
Mycophenolic acid | 24280-93-1 | sc-200110 sc-200110A | 100 mg 500 mg | $69.00 $266.00 | 8 | |
Mycophenolic acid inhibits inosine monophosphate dehydrogenase, an enzyme involved in guanine nucleotide synthesis. It may affect LINC00239 indirectly by perturbing nucleotide metabolism. | ||||||
DRB | 53-85-0 | sc-200581 sc-200581A sc-200581B sc-200581C | 10 mg 50 mg 100 mg 250 mg | $43.00 $189.00 $316.00 $663.00 | 6 | |
DRB inhibits RNA polymerase II, blocking transcription and potentially reducing LINC00239 expression by preventing its synthesis. | ||||||
Cordycepin | 73-03-0 | sc-203902 | 10 mg | $101.00 | 5 | |
Cordycepin, a nucleoside analog, is incorporated into RNA during synthesis, leading to premature termination. It may affect LINC00239 expression by causing early termination of its transcription. | ||||||